NRXP NRX PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2025 - Capital Structure Update NRx Pharmaceuticals Inc. announced the issuance of approximately $16.3 million in senior secured convertible promissory notes and common stock purchase warrants, along with a registered direct offering of 1,215,278 shares at $2.88 per share, aiming to use the proceeds for general working capital.Get access to all SEC 8-K filings of the NRX PHARMACEUTICALS INC